NCT05175547View on ClinicalTrials.gov

Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 30, 2021

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
Stroke, AcuteBlood PressureMechanical Thrombectomy
Interventions
DRUG

Clevidipine

Blood pressure management with Clevidipine

Trial Locations (1)

43606

ProMedica Toledo Hospital, Toledo

Sponsors
All Listed Sponsors
lead

ProMedica Health System

OTHER

NCT05175547 - Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter